OncLiveKite Unveils Novel BCMA-Directed CAR T-cell Therapy – OncLiveOncLiveA novel target, B-cell maturation antigen, has been identified for future therapeutic development as chimeric antigen receptor T-cell therapy for patients with …and more&… Continue reading
Baylor Mesothelioma Doctor Has High Hopes for Preoperative ImmunotherapyMesothelioma.com (blog)Last September, a new mesothelioma clinical trial began at the Baylor College of Medicine Mesothelioma Treatment Center. The clinical trial is a new multimod… Continue reading
Science DailyUsing CRISPR to reverse retinitis pigmentosa and restore visual …Science DailyUsing the gene-editing tool CRISPR/Cas9, researchers have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing … Continue reading
UC San Diego HealthUsing CRISPR to Reverse Retinitis Pigmentosa and Restore Visual FunctionUC San Diego HealthUsing the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC … Continue reading
|
ARMO BioSciences Announces Clinical Data Presentation for Immunotherapy AM0010 at the 12th European …
Yahoo Finance REDWOOD CITY, Calif., April 21, 2017 /PRNewswire/ — ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced that clinical data on the Company’s lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) … |
|
Preventing Graft-Versus-Host Disease in Stem Cell-Transplant Recipients
Genetic Engineering & Biotechnology News (press release) An international group of scientists led by investigators at the Technical University of Munich (TUM) says it has discovered molecular mechanisms that might prevent the development of graft-versus-host disease (GVHD) in individuals receiving stem cell … |